ImmuneMed, Inc. develops anti-virus substances and other health related research. The firm’s products include Leptospira RAPID, Scrub Typhus, AFI, Hanta, and Murine Typhus RAPID. The company was founded by Yoon-Won Kim in 2000 and is headquartered in Chuncheon, South Korea.

Nordic Bioscience is a biotech firm that studies extracellular matrix (ECM). It uses Protein Fingerprint technology to identify ECM fragments released from affected tissues and to develop blood-based biomarker assays to quantify disease activity in the pursuit of precision medicine. Nordic Bioscience is based in Herlev, Denmark, and operates a high-quality standard laboratory that conducts clinical trials in accordance with Good Clinical Laboratory Practice (GCLP) and is accredited by the College of American Pathologists (CAP), and has an ISO9001 certificate.

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products, including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

SurExam Bio-Tech Co., Ltd. provides personalized medical system solutions focused on tumor molecular diagnostic products and clinical medicine testing services. Its products include medical kits. It also provides medical testing services. The company was founded on November 28, 2006 and is headquartered in Guangzhou, China.

Chuzhou Luoda Biotechnology Co., Ltd., established on 2013-07-31, Business scope includes biotechnology extension services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Cellectis AB, a subsidiary of Takara Holdings, Inc., is a Swedish company located in Gothenburg. The firm manufactures and distributes stem cell-related products. On September 04, 2014 Takara Bio, Inc. acquired Cellectis AB from Cellectis SA.

Konkuk University Industry-Academic Cooperation Foundation increases the competitiveness of industries by linking company and university.

La Roche Posay Laboratoire Pharmaceutique SA provides dermatology services. The firm offers face masks, moisturizer, toner, eye cream, mineral, body, and kids sunscreen. The company is headquartered in Nouvelle, France.

Nanjing Shiqi Pharmaceutical Technology Co., Ltd., established on 2013-11-08, Business scope includes pharmaceutical,biology,chemical industry,Environmental friendly,new energy,new material,Healthy food,Cosmetic technology research and development,technical consulting,Technical Services,technology transfer;Chemical raw materials and products,Class I medical device,Chemical machinery and equipment,experiment equipment,Instrumentation,electronics,Daily necessities,plastic products,stationery,office equipment,primary agricultural products,Mineral sales;Self-operated and agent import and export business of various commodities and technologies(Except for commodities and technologies that the state restricts the company to operate or prohibits the import and export of).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

Aurelium BioPharma Inc., develops therapeutics and diagnostics for the treatment of drug-resistant cancers. The company has developed several diagnostic tests for the detection of breast, ovarian as well as drug-resistant cancers. The firm has a strong drugable pipeline of novel targets and complimentary diagnostic products that are utilized in its strategic collaborations and out-licensing efforts. The company was founded in May 1998 and is headquartered in Laval, Canada.

CuraGen Corporation is a biopharmaceutical development company that develops novel therapeutics for the treatment of cancer in the United States and Europe. Its therapeutics is based on novel targets from the human genome that play a role in proven mechanisms underlying disease. The Company's strategy continues to be focused on advancing its pipeline of pipeline of protein, antibody, and small molecule drugs in the areas of oncology, inflammatory diseases, and diabetes, promising therapeutics through clinical and preclinical development. CuraGen Corporation was founded in 1991 and is headquartered in Branford, Connecticut. As of October 1, 2009, CuraGen Corporation operates as a subsidiary of Celldex Therapeutics, Inc.

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

SOMAR Corp. engages in the manufacture and trading of fine chemicals, high functional resins and coated products. It operates through the following segments: High Functional Materials, Environmental Materials, Food Materials and Others. The High Functional Materials segment deals with coating products, high performance resins, electronic materials, and functional resin. The Environmental Materials segment provides fine chemicals and paper manufacturing chemicals. The Food materials segment manufactures, purchases and sells food materials. The Others segment offers food ingredients. The company was founded by Tadashi Sotani in 1943 and is headquartered in Tokyo, Japan.

Osteoneurogen specializes in anti-IPF and senotherapeutics. The company develops fibrosis and autoimmune disease treatments based on plant-based pharmacological compounds known as chromone scaffold compounds.

A+ Science AB plans and conducts clinical trials for pharmaceutical and medical device companies. It offers outsourced research services to pharmaceutical companies. The company was founded in 1997 and is headquartered in Stockholm, Sweden.

Aluda Pharmaceuticals, Inc. is an American private company located in Menlo Park, CA, that discovers and develops therapeutics. It was founded by Ruihuan Chen, Lian Mo and Deebie Symmes. Ruihuan Chen has been the CEO of the firm since 2015.\nThe company says this about itself: Aluda discovers and develops novel drugs related to the signaling between cells that is central to immunological defense, inflammation, and disease pathogenesis. Programs include both new and previously explored drug targets with a focus on inflammation, oncology, and autoimmune.

Regents of The University of Michigan provides administers bonds on behalf of the University. The company is headquartered in Ann Arbor, MI.

Agios Pharmaceuticals is a biopharmaceutical company, discovers and develops therapeutics in the field of cancer metabolism. It also develops drugs that focus on glycolysis, fatty acid metabolism, and autophagy. The company's therapeutics are used in the areas of autoimmune, inflammatory, and neurological diseases. Agios Pharmaceuticals was formerly known as CANCER METABOLISM THERAPEUTICS And changed its name to Agios Pharmaceuticals In April 2008. The company is based in Cambridge, Massachusetts.